Return on Investment (RoI) Tools

Image depicting return on investment

Contact us

Got a question about the tools or want help developing a strategy?

Contacts are detailed in each topic.

 

Tools for public health commissioners and decision-makers to model the effects of interventions, to estimate costs against the value of benefits and improvements.

Tobacco use remains the UK’s single greatest cause of preventable illness and avoidable death, with 100,000 people dying each year from smoking-related diseases, including cancer[1].

These evidence-based tools are designed to help decision makers determine which tobacco control interventions will have the greatest impact on lowering the harms caused by tobacco.

ASH Ready Reckoner

A tool demonstrating the local economic impacts of smoking and tobacco use.

 

NICE Tobacco Return on Investment (ROI) Tool

Evaluates a portfolio of tobacco control interventions and models the economic returns that can be expected in different payback timescales. Different interventions, including pharmacotherapies and support and advice, can be mixed and matched to see which intervention portfolio or package provides the best 'value for money', compared with 'no-services' or any other specified package.

 

Got a question about the tools or want help developing a strategy? Email us

 

[1] Peto R et al. Mortality from smoking in developed countries 1950-2010. University of Oxford, UK. 2012. pp.512-523.

Obesity is the single biggest preventable cause of cancer after smoking. Obesity is linked to thirteen different types of cancer, including two of the most common – bowel and breast – and two of the hardest to treat – pancreatic and oesophageal.[1] 

Our research shows that if current trends continue, obesity could cause 670,000 cases of cancer over the next 20 years.[2]

There currently are no RoI tools for obesity, but there is a tool for physical activity. 

NICE Physical activity Return on Investment (ROI) Tool

Evaluates a portfolio of interventions in a geographical area. It then models the expected economic returns in different payback timescales. The different interventions included in the tool can be mixed and matched to see which package(s) gives the best value for money, compared with no interventions.

 

Got a question about the tools or want help developing a strategy? Email us

 

[1] Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer — Viewpoint of the IARC Working Group. N Engl J Med 2016; 375:794-798
[2] Cancer Research UK and the UK Health Forum. Tipping the scales: why preventing obesity makes economic sense’. UK. 2016.

Alcohol causes 7 types of cancer, including breast, mouth and bowel cancers. Alcohol is responsible for around 4% of UK cancers, about 12,800 cases per year.[1]

This evidence-based tool is designed to help decision makers determine which alcohol interventions will have the greatest impact on lowering the harms caused by alcohol.

NICE Alcohol Return on Investment (ROI) Tool

Evaluates a portfolio of interventions in a geographical area. It then models the expected economic returns in different payback timescales. The different interventions included in the tool can be mixed and matched to see which package(s) gives the best value for money, compared with no interventions.

 

Got a question about the tools or want help developing a strategy? Email us

 

[1] Parkin, DM., et al., Cancers attributable to the consumption of alcohol in the UK in 2010. Br J Cancer. 2011. 106(S2):S14- S18.

Bowel cancer accounts for more than 1 in 10 cancer cases and 1 in 10 cancer deaths in the UK. When diagnosed at its earliest stage, more than 9 in 10 people with bowel cancer will survive their disease for five years or more, compared with less than 1 in 10 people when diagnosed at the latest stage.[1]

These evidence-based tools are designed to help decision makers determine which interventions will have the greatest impact on making diagnosis earlier and improving outcomes for patients.

PHE Cost-Effective Commissioning of Colorectal Cancer Care Tools

These resources help clinical commissioning groups (CCGs), local authorities and Health and Wellbeing Boards to make the case at a local level for investing in earlier diagnosis and intervention to improve patient outcomes.

The return on investment tool helps CCGs to estimate costs and benefits at a local level. The report explains the costs of colorectal cancer across the care pathway. It supports NHS England work on earlier detection and diagnosis.

 

Got a question about the tools or want help developing a strategy? Email us

 

Last reviewed

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page